A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study

Daisuke Saito; Fumihito Hirai; Kazuhiko Uchiyama; Tomohisa Takagi; Yuji Naito; Noritaka Takatsu; Hiroshi Tanabe; Mitsuo Kishimoto; Minoru Matsuura; Jun Miyoshi; Kenji Watanabe; Motohiro Esaki; Makoto Naganuma; Tadakazu Hisamatsu

doi:10.1055/a-2067-8943

Endoscopy International Open, Table of Contents

CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(05): E504-E512
DOI: 10.1055/a-2067-8943

Original article

A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study

Daisuke Saito

¹Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan

,

Fumihito Hirai

²Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan

,

Kazuhiko Uchiyama

³Department of Gastroenterology and Hepatology, Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

,

Tomohisa Takagi

³Department of Gastroenterology and Hepatology, Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

,

Yuji Naito

⁴Department of Human Immunology and Nutrition Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

,

Noritaka Takatsu

⁵Inflammatory bowel disease center, Fukuoka University Chikushi Hospital, Fukuoka, Japan

,

Hiroshi Tanabe

⁶Department of Pathology, Fukuoka University Chikushi Hospital, Fukuoka, Japan

,

Mitsuo Kishimoto

⁷Department of Surgical Pathology, Kyoto City Hospital, Kyoto, Japan

,

Minoru Matsuura

¹Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan

,

Jun Miyoshi

¹Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan

,

Kenji Watanabe

⁸Center for Inflammatory Bowel Disease, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Hyogo, Japan

,

Motohiro Esaki

⁹Department of Gastroenterology and Hepatology, Saga University, Saga, Japan

,

Makoto Naganuma

¹⁰Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan

,

Tadakazu Hisamatsu

¹Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan

› Author Affiliations

Abstract

Background and study aims An important therapeutic aim in ulcerative colitis (UC) is endoscopic remission. Although an endoscopic score with white light imaging (WLI) is mainly used to evaluate endoscopic findings, the usefulness of linked color imaging (LCI) has been reported. We evaluated the relationship between LCI and histopathological findings and attempted to establish a new LCI endoscopic evaluation index for UC.

Patients and methods This study was conducted at Kyorin University, Kyoto Prefectural University, and Fukuoka University Chikushi Hospital. Ninety-two patients with a Mayo endoscopic subscore (MES) ≤ 1 who underwent colonoscopy for UC in clinical remission were included. LCI index was defined as redness (R) (Grade 0–2), area of inflammation (A) (Grade 0–3), and lymphoid follicles (L) (Grade 0–3). Histological healing was defined as Geboes score < 2B.1. Endoscopic and histopathological scores were determined by central judgment.

Results In 92 patients, 85 biopsies from the sigmoid colon and 84 biopsies from the rectum (total 169 biopsies) were evaluated. There were 22, 117, and 30 cases of Grades 0, 1, and 2, respectively in LCI index-R; 113, 34, 17, and five cases of Grades 0, 1, 2, and 3, respectively, in LCI index-A; and 124, 27, 14, and four cases of Grades 0, 1, 2, and 3, respectively, in LCI index-L. Histological healing was achieved in 84.0 % of the cases (142 of 169), and there were significant associations with histological healing or non-healing in LCI index-R (P = 0.013) and A (P = 0.0014).

Conclusions A new LCI index is useful for predicting histological healing in UC patients with MES ≤ 1 and clinical remission.

Full Text

References

References
1 Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365: 1713-1725
2 Ungaro R, Mehandru S, Allen PB. et al. Ulcerative colitis. Lancet 2017; 389: 1756-1770
3 Dulai PS, Jairath V. How do we treat inflammatory bowel diseases to aim for endoscopic remission?. Clin Gastroenterol Hepatol 2020; 18: 1300-1308
4 Annese V, Daperno M, Rutter MD. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
5 Baars JE, Nuij VJ, Oldenburg B. et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis 2012; 18: 1634-1640
6 Rosenberg L, Lawlor GO, Zenlea T. et al. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis 2013; 19: 779-784
7 Colombel JF, Rutgeerts P, Reinisch W. et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141: 1194-1201
8 Meucci G, Fasoli R, Saibeni S. et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis 2012; 18: 1006-1010
9 Froslie KF, Jahnsen J, Moum BA. et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133: 412-422
10 Dulai PS, Levesque BG, Feagan BG. et al. Assessment of mucosal healing in inflammatory bowel disease: review. Gastrointest Endosc 2015; 82: 246-255
11 Lemmens B, Arijs I, Van Assche G. et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1194-1201
12 Zenlea T, Yee EU, Rosenberg L. et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study. Am J Gastroenterol 2016; 111: 685-690
13 Rosenberg L, Nanda KS, Zenlea T. et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol 2013; 11: 991-996
14 Korelitz BI, Sultan K, Kothari M. et al. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. World J Gastroenterol 2014; 20: 4980-4986
15 Bitton A, Peppercorn MA, Antonioli DA. et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120: 13-20
16 Ozaki R, Kobayashi T, Okabayashi S. et al. Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa. J Crohns Colitis 2018; 12: 1288-1294
17 Turner D, Ricciuto A, Lewis A. et al. STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2021; 160: 1570-1583
18 Fukuda H, Miura Y, Hayashi Y. et al. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol 2015; 8: 385-389
19 Uchiyama K, Takagi T, Kashiwagi S. et al. Assessment of endoscopic mucosal healing of ulcerative colitis using linked colour imaging, a novel endoscopic enhancement system. J Crohns Colitis 2017; 11: 963-969
20 Takagi T, Uchiyama K, Kajiwara-Kubota M. et al. The efficacy of linked color imaging for the endoscopic diagnosis of mucosal healing in quiescent ulcerative colitis. J Gastroenterol Hepatol 2021; 36: 2448-2454
21 Nakase H, Uchino M, Shinzaki S. et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 2021; 56: 489-526
22 Rutgeerts P, Sandborn WJ, Feagan BG. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476
23 Lewis JD, Chuai S, Nessel L. et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008; 14: 1660-1666
24 Nakarai A, Kato J, Hiraoka S. et al. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count. World J Gastroenterol 2014; 20: 18367-18374
25 Rutgeerts P, Sandborn WJ, Feagan BG. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476
26 Jauregui-Amezaga A, Geerits A, Das Y. et al. A simplified Geboes Score for ulcerative colitis. J Crohns Colitis 2017; 11: 305-313
27 Mosli MH, Feagan BG, Zou G. et al. Development and validation of a histological index for UC. Gut 2017; 66: 50-58
28 Sands BE, Sandborn WJ, Panaccione R. et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2019; 381: 1201-1214
29 Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measurement 1960; 20: 37-46
30 Bryant RV, Winer S, Travis SPL. et al. Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. J Crohns Colitis 2014; 8: 1582-1597
31 Yoon H, Jangi S, Dulai PS. et al. Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis. Gastroenterology 2020; 159: 1262-1275
32 Hayashi R, Ueno Y, Tanaka S. et al. Rectal lymphoid follicle aphthous lesions frequently progress to ulcerative colitis with proximal extension. Intern Med 2019; 58: 625-631